Risks from Deferring Treatment for Genitourinary Cancers: A Collaborative Review to Aid Triage and Management During the COVID-19 Pandemic[Formula presented]
Academic Article
Publication Date:
2020
abstract:
The coronavirus disease 2019 (COVID-19) pandemic is leading to delays in the treatment of many urologic cancers. Patients and clinicians should consider the oncologic risk of delayed cancer intervention versus the risks of COVID-19 to patients, treating health care professionals, and the health care system.
Iris type:
1.1.3. Articolo in Rivista - Editorial, Comment, Reply
Keywords:
Bladder cancer; Coronavirus; Coronavirus disease 2019; Delayed treatment; Kidney cancer; Penile cancer; Prostate cancer; Sstemic therapy; Surgery; Testicular cancer; Upper tract urothelial carcinoma; COVID-19; Combined Modality Therapy; Coronavirus Infections; Humans; Pneumonia, Viral; Risk Factors; SARS-CoV-2; Time-to-Treatment; Triage; Urogenital Neoplasms; Betacoronavirus; Disease Management; Pandemics
List of contributors:
Wallis, C. J. D.; Novara, G.; Marandino, L.; Bex, A.; Kamat, A. M.; Karnes, R. J.; Morgan, T. M.; Mottet, N.; Gillessen, S.; Bossi, A.; Roupret, M.; Powles, T.; Necchi, A.; Catto, J. W. F.; Klaassen, Z.
Published in: